Literature DB >> 12499428

Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group.

J E van der Wal1, M A J A Hermsen, H J P Gille, N Y N Schouten-Van Meeteren, A C Moll, S M Imhof, G A Meijer, J P A Baak, P van der Valk.   

Abstract

BACKGROUND: Retinoblastoma is the most common intraocular malignancy in childhood and is responsible for approximately 1% of all deaths caused by childhood cancer. AIMS/
METHODS: Comparative genomic hybridisation was performed on 13 consecutive, histologically confirmed retinoblastomas to analyse patterns of chromosomal changes and correlate these to clinicopathological variables. Six cases were hereditary and seven cases were sporadic.
RESULTS: In 11 of the 13 tumours chromosomal abnormalities were detected, most frequently gains. Frequent chromosomal gains concerned 6p (46%), 1q (38%), 2p, 9q (30%), 5p, 7q, 10q, 17q, and 20q (23%). Frequent losses occurred at Xq (46%), 13q14, 16q, and 4q (23%). High level copy number gains were found at 5p15 and 6p11-12. A loss at 13q14 occurred in three cases only. Relatively few events occurred in the hereditary cases (27) compared with the non-hereditary cases (70 events). The number of chromosomal aberrations in these 13 retinoblastomas showed a bimodal distribution. Seven tumours showed less than four chromosomal aberrations, falling into a low level chromosomal instability (CIN) group, and six tumours showed at least eight aberrations, falling into a high level CIN group. In the low level CIN group the mean age was half that seen in the high level CIN group, there were less male patients, and there were more hereditary and bilateral cases. Microsatellite instability was not detected in either of the two groups.
CONCLUSION: Despite the complex pattern of genetic changes in retinoblastomas, certain chromosomal regions appear to be affected preferentially. On the basis of the number of genetic events, retinoblastomas can be divided in low and a high level chromosomal instability groups, which have striking differences in clinical presentation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499428      PMCID: PMC1769844          DOI: 10.1136/jcp.56.1.26

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

Review 1.  Comparative genomic hybridisation.

Authors:  M M Weiss; M A Hermsen; G A Meijer; N C van Grieken; J P Baak; E J Kuipers; P J van Diest
Journal:  Mol Pathol       Date:  1999-10

2.  N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma.

Authors:  F Doz; M Peter; G Schleiermacher; P Vielh; P Validire; M Putterman; V Blanquet; L Desjardins; J L Dufier; J M Zucker; V Mosseri; G Thomas; H Magdelénat; O Delattre
Journal:  Eur J Cancer       Date:  1996-04       Impact factor: 9.162

Review 3.  Genetic instability and darwinian selection in tumours.

Authors:  D P Cahill; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Trends Cell Biol       Date:  1999-12       Impact factor: 20.808

4.  Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization.

Authors:  D Chen; B L Gallie; J A Squire
Journal:  Cancer Genet Cytogenet       Date:  2001-08

5.  Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses.

Authors:  A Mairal; E Pinglier; E Gilbert; M Peter; P Validire; L Desjardins; F Doz; A Aurias; J Couturier
Journal:  Genes Chromosomes Cancer       Date:  2000-08       Impact factor: 5.006

6.  Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization.

Authors:  S Herzog; D R Lohmann; K Buiting; A Schüler; B Horsthemke; H Rehder; H Rieder
Journal:  Hum Genet       Date:  2001-02       Impact factor: 4.132

7.  Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification.

Authors:  E Chaum; R M Ellsworth; D H Abramson; B G Haik; F D Kitchin; R S Chaganti
Journal:  Cytogenet Cell Genet       Date:  1984

8.  Multiple karyotypic changes in retinoblastoma tumor cells: presence of normal chromosome No. 13 in most tumors.

Authors:  H A Gardner; B L Gallie; L A Knight; R A Phillips
Journal:  Cancer Genet Cytogenet       Date:  1982-07

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Comparative genomic hybridization: a new tool in cancer pathology.

Authors:  M A Hermsen; G A Meijer; J P Baak; H Joenje; J J Walboomers
Journal:  Hum Pathol       Date:  1996-04       Impact factor: 3.466

View more
  20 in total

1.  Competing endogenous RNA: A novel posttranscriptional regulatory dimension associated with the progression of cancer.

Authors:  Qingsong Dai; Jixia Li; Keyuan Zhou; Tong Liang
Journal:  Oncol Lett       Date:  2015-09-14       Impact factor: 2.967

2.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

3.  Expression of multidrug resistance proteins in retinoblastoma.

Authors:  Swati Shukla; Arpna Srivastava; Sunil Kumar; Usha Singh; Sandeep Goswami; Bhavna Chawla; Mandeep Singh Bajaj; Seema Kashyap; Jasbir Kaur
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

4.  Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.

Authors:  Kwong Wai Choy; Tom C Lee; Kin Fai Cheung; Dorothy S P Fan; Kwok Wai Lo; Katherine L Beaverson; David H Abramson; Dennis S C Lam; Christopher B O Yu; Chi Pui Pang
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

5.  Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.

Authors:  Mellone N Marchong; Christine Yurkowski; Clement Ma; Clarellen Spencer; Sanja Pajovic; Brenda L Gallie
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

6.  Variability in retinoblastoma genome stability is driven by age and not heritability.

Authors:  Ashley Polski; Liya Xu; Rishvanth K Prabakar; Xiaowu Gai; Jonathan W Kim; Rachana Shah; Rima Jubran; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Genes Chromosomes Cancer       Date:  2020-06-09       Impact factor: 5.006

Review 7.  Overview of recurrent chromosomal losses in retinoblastoma detected by low coverage next generation sequencing.

Authors:  A J García-Chequer; A Méndez-Tenorio; G Olguín-Ruiz; C Sánchez-Vallejo; P Isa; C F Arias; J Torres; A Hernández-Angeles; M A Ramírez-Ortiz; C Lara; M L Cabrera-Muñoz; S Sadowinski-Pine; J C Bravo-Ortiz; G Ramón-García; J Diegopérez-Ramírez; G Ramírez-Reyes; R Casarrubias-Islas; J Ramírez; M A Orjuela; M V Ponce-Castañeda
Journal:  Cancer Genet       Date:  2015-12-15

8.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Laura Poliseno; Leonardo Salmena; Jiangwen Zhang; Brett Carver; William J Haveman; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

9.  Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma.

Authors:  Mary E Kim; Ashley Polski; Liya Xu; Rishvanth K Prabakar; Chen-Ching Peng; Mark W Reid; Rachana Shah; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

10.  Insights from mouse models into human retinoblastoma.

Authors:  David Macpherson
Journal:  Cell Div       Date:  2008-05-19       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.